Search results
Results From The WOW.Com Content Network
May 17, 2024 at 11:14 AM. (Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute ...
July 2, 2024 at 3:55 AM. By Sam Tobin. LONDON (Reuters) -Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a mixed ruling on ...
Pfizer and BioNTech set their price at $120, and Moderna doses will be $129. Novavax shots will be $130 per dose. The vaccine is recommended for everyone six months and older.
Moderna, Pfizer/BioNTech and relative newcomer to the COVID vaccine market Novavax have created versions of their shots aimed at the XBB.1.5 subvariant, the dominant variant through most of 2023.
(Reuters) -The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the ...
New, modified versions of Pfizer’s and Moderna’s existing COVID-19 vaccines received a green light from the Food and Drug Administration to be used as booster shots on Wednesday, Aug. 31.
Whereas Pfizer’s management increased vaccine revenue estimates by $10 billion over their early 2021 view, Moderna now sees vaccine revenue in the $15 to $18 billion range, down from earlier ...
"It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation and chief innovation officer for UC San Francisco, said at a campus town hall last week.